References
- International Society for Blood Transfusion. Names for I (ISBT 027) blood group alleles. www.isbtweb.org.
- Happ H, Weh E, Costakos D, Reis LM, Semina EV. Case report of homozygous deletion involving the first coding exons of the upstream region of GCNT2 isoforms A and B and part of the upstream region of TFAP2A in congenital cataract. BMC Med Genet 2016;17:64.
- Irum B, Khan SY, Ali M, et al. Deletion at the GCNT2 locus causes autosomal recessive congenital cataracts. PLoS One 2016;11:e0167562.
- Nakamura K, Sawaki H, Yamashita K, Watanabe M, Narimatsu H. Identification of epigenetic silencing of GCNT2 expression by comprehensive real-time PCR screening in colorectal cancer. J Clin Oncol 2014;32(Suppl 3):506.
- Onodera T. A new IGNT allele found in the adult i-negative in Japanese without congenital cataracts. Vox Sang 2011;101(Suppl 1):262.
- Aldahmesh MA, Khan AO, Mohamed JY, et al. Genomic analysis of pediatric cataract in Saudi Arabia reveals novel candidate disease genes. Genet Med 2010;14:955–62.
- Brock G, Kakar N, Hoch J, et al. An Alu repeat-mediated genomic GCNT2 deletion underlies congenital cataracts and adult I blood group. Hum Genet 2012;131:209–16.
- Li J, Leng Y, Han S, et al. Clinical and genetic characteristics of Chinese patients with familial or sporadic pediatric cataract. Orpahnet J Rare Dis 2019;13:94.
- Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. 3rd ed. Cambridge, MA: Elsevier, 2012.
- Yu L-C, Lin M. Molecular genetics of the blood group I system and the regulation of I antigen expression during erythropoiesis and granulocytopoiesis. Curr Opin Hematol 2011;18:421–6.
- Cooling L. Polylactosamines, there’s more than meets the “Ii”: a review of the I system. Immunohematology 2010;26:133–55.
- Twu Y-C, Hsieh C-Y, Lin M, Tzeng C-H, Sun C-F, Yu L-C. Phosphorylation status of transcription factor C/EBPa determines cell-surface poly-LacNAc branching (I antigen) formation in erythropoiesis and granulocytopoiesis. Blood 2010;115:2491–9.
- Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leuk Biol 2009;86:237–50.
- Tajan M, de Rocca Seraa A, Valet P, Edouard T, Yart A. SHP2 sails from physiology to pathology. Eur J Med Genet 2015;58:509–25.
- Liao Y-J, Lee Y-H, Chang F-L, Ho H, Huang C-H, Tsu T-C. The SHP2-ERK2 signaling pathway regulates branched I antigen formation by controlling the binding of CCAAT/enhancer binding protein a to the IGNTC promoter region during erythroid differentiation. Transfusion 2016;56:2691–702.
- Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet 2018;392: 777–86.
- Yu Y, Ebenezer D, Bhattacharyya S, et al. High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. J Biol Chem 2013;288:8805–14.
- Lessard S, Beaudoin M, Benkirane K, Lettre G. Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors. Genome Med 2015;7:1.
- Murakami M, Yoshimoto T, Nakabayashi K, et al. Integration of transcriptome and methylome analysis of aldosterone-producing adenomas. Eur J Endocrin 2015;173:185–95.
- Nakamura K, Yamashita K, Sawaki H, et al. Aberrant methylation of GCNT2 is tightly regulated to lymph node metastasis of primary CRC. Anticancer Res 2015;35:1411–22.
- Qin Y, Zhao L, Wang X, et al. MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells. Glycobiology 2017;27:306–17.
- Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanism of miRNA regulation. Genomics Proteomics Bioinformatics 2009;7:147–54.
- De Vasconcellos JF, Brynes C, Lee YT, et al. Tough decoy targeting of predominant let-7 miRNA species in adult human hematopoietic cells. J Transl Med 2017;15:169.
- Chen B-Z, Yu S-L, Singh S, et al. Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells. Cell Biol Int 2011;35:29–37.
- Chao C-C, Wu P-H, Huang H-C, et al. Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer. FEBS Lett 2017;591:1902–17.
- Nabi IR, Shankar J, Dennis JW. The galectin lattice at a glance. J Cell Science 2015;128:2213–19.
- Arthur CM, Baruffi MD, Cummings RD, Stowell SR. Evolving mechanistic insights into galectin functions. In Stowell SR, Cummings RD, Eds. Galectins: methods and protocols (Methods in molecular biology, vol. 1207). New York: Springer, 2015:1–36.
- Coughlin S, Noviski M, Mueller JL, et al. An extracatalytic function of CD45 in B-cells is mediated by CD22. Proc Natl Acad Sci U S A 2015;112:E6515–24.
- Giovannone N, Liang J, Antonopoulos A, et al. Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nat Commun 2018;9:3287.
- Lee Y-H, Liao Y-J, Huang C-H, Chang F-L, Fan T-H, Twu Y-C. Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction. Transfusion 2017;57:1040–51.
- Dong Z, Zhu X, Li Y, et al. Oncogenomic analysis identifies novel biomarkers for tumor stage myosis fungoides. Medicine 2018;97:e10871.
- Boehler KR, Bhattacharya S, Kropp EM, et al. A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes and drug targets. Stem Cell Rep 2014;3:185–203.
- Noda S, Horiguchi K, Ichikawa H, Miyoshi H. Repopulating activity of ex vivo-expanded murine hematopoietic stem cells resides in the CD48-c-KIT+Sca-1+Lineage marker-cell population. Stem Cells 2008;26:646–55.
- Ji H, Ehrlich LIR, Seita J, et al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 2010;467:338–42.
- Heiskanen A, Hirvonen T, Salo H, et al. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 2009;26:367–84.
- Hirvonen T, Suila H, Kotovuori A, et al. The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev 2012;21:455–64.
- Zhang H, Meng F, Wu S, et al. Engagement of I-branching β1,6 N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-β signaling. Cancer Res 2011;71:4846–56.
- Burchell J, Wang D, Taylor-Papadimitriou J. Detection of the tumour-associated antigens recognized by HMFG 1 and 2 in serum from patients with breast cancer. Int J Cancer 1984;34:763–8.
- Dube VE, Haid M, Chmiel JS, Anderson B. Serum cold agglutinin and IgM levels in breast carcinoma. Breast Cancer Res Treat 1984;4:105–8.
- Gaudet MM, Kuchenbaeker KB, Vijai J, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013;9:e1003173.
- Mikami J, Tobisawa Y, Yoneyama T, et al. I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiness by enhancing alph5beta-1 integrin signaling. Cancer Sci 2016;107:359–68.
- Gao C, Zhang H, Zhang Y, et al. Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array. J Biol Chem 2014;289:16462–77.
- Sweeney JG, Liang J, Antonopoulos A, et al. Loss of GCNT2/I-branched glycans enhances melanoma growth and survival. Nature Comm 2018;9:3368.
- Fidalgo F, Rodrigues TC, Silva AG, et al. Role of rare germline copy number variation in melanoma-prone patients. Future Oncol 2016;12:1345–57.
- Yang X, Lei S, Long J, Liu X, Wu Q. MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1a. Mol Med Rep 2016;13:5241–47.
- Micevic G, Theodosakis N, Bosenberg M. Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clin Epigenet 2017;9:34.